AMPK has been described as tumorigenic and tumor suppressing in tissue-specific contexts and in different cellular energy states (Ríos et al., 2013; Faubert et al., 2013; Shaw et al., 2004; Inoki et al., 2006; Jones et al., 2005). The gene discussed is PRKAA2; the disease is neoplasm.